Similar to schizophrenia, reductions of cortical GAD67 expression and alterations in GABAA and GABAB receptor levels were reported in MDD (Fatemi et al. 2005; Abdallah et al. 2015; Fogaca and Duman 2019). This evidence concerns the gene GAD1 and major depressive disorder.